White label – Pompe disease - ClinicalTrials.eu

Study of ExPEC9V vaccine for preventing invasive E.

Not recruiting

3 1
Investigated Drugs:
- Ecoo15
- Ecoo16
- Ecoo18A
+1
Study on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Hereditary neuropathic amyloidosis
- Cardiac amyloidosis
Investigated Drugs:
- Patisiran
- Vutrisiran
+1
Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

Not recruiting

2 1 1 1
Investigated Diseases:
- Factor IX deficiency
Investigated Drugs:
- Etranacogene Dezaparvovec
Study on the Effectiveness and Safety of Ibrutinib and Rituximab for Patients with Indolent Mantle Cell Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Mantle cell lymphoma
Investigated Drugs:
- Ibrutinib
- Rituximab
Study on the Effects of Tacrolimus on Blood Sugar Levels in Patients Undergoing Dialysis Before Kidney Transplantation

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemodialysis
Investigated Drugs:
- Tacrolimus
Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG

Not recruiting

3 1 1
Investigated Drugs:
- Sasanlimab
Study on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma

Not recruiting

2 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis

Not recruiting

3 1 1
Investigated Diseases:
- Primary amyloidosis
- Cardiac amyloidosis
Investigated Drugs:
+2
Study on Dosing Methods of Cisplatin for Women with Advanced Ovarian Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- Cisplatin
Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Ceritinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies